Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
To demonstrate that intravitreal ranibizumab 0.2 mg has superior efficacy to laser therapy in the treatment of ROP as measured by the absence of active ROP and absence of unfavorable structural outcomes in both eyes 24 weeks after starting investigational treatment.
- Retinopathy of prematurity (ROP)